4-Substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors
申请人:Wyeth Holdings Corporation
公开号:US20040214812A1
公开(公告)日:2004-10-28
The present invention relates to novel, low molecular weight broad spectrum compounds in particular to a class of 4-substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid or their derivatives which have &bgr;-lactamase inhibitory and antibacterial properties. The compounds are therefore useful in the treatment of antibacterial infections in humans or animals, either alone or in combination with other antibiotics.
本发明涉及新型低分子量广谱化合物,特别是一类具有&bgr;-内酰胺酶抑制和抗菌特性的4-取代或未取代-7-氢-1,4-硫氮杂卓-7-[双环或三环杂芳基]取代-3,6-二羧酸或其衍生物。因此,这些化合物可用于治疗人类或动物的抗菌感染,既可单独使用,也可与其他抗生素联合使用。